Clinical roundtable monograph. Choosing an appropriate therapy for lower-risk MDS in the community setting.
Lyons
Roger M
RM
Cancer Care Centers of South Texas, US Oncology, San Antonio, TX, USA.
D001374:Azacitidine / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D015254:DNA Modification Methylases / Q000037:antagonists & inhibitors*; D000077209:Decitabine; D004334:Drug Administration Schedule; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000145:classification / Q000188:drug therapy*
D000077209:Decitabine; D015254:DNA Modification Methylases; D001374:Azacitidine